QA: TherapeuticsMD Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000025743_2023_TherapeuticsMD_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000025743, TherapeuticsMD Inc.

  xvar xval
0 AssetsCurrent 55,351,000
1 IntangibleAssetsNetIncludingGoodwill 6,943,000
2 PropertyPlantAndEquipmentNet 78,000
3 remainder_Assets 28,086,000
4 LiabilitiesCurrent 46,839,000
5 LiabilitiesNoncurrent 8,476,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,397,000
8 SellingGeneralAndAdministrativeExpense 57,903,000
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 9,472,000
11 remainder_Revenues 69,963,000
12 remainder_NetIncome 110,806,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 90,458,000
1 Liabilities 55,315,000
2 Expenses 68,772,000
3 Revenues 69,963,000
4 StockholdersEquity 35,143,000
5 NetIncome 111,997,000
6 ComprehensiveNetIncome 111,997,000
7 BaseVar 197,657,000
8 EconomicCapitalRatio 2.37

Edgar->Model Mapping

Feature Distribution

Change over Time